A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MUC16ecto+ recurrent high-grade serous ovarian cancer (HGSOC) Meeting Abstract
| Authors: | O'Cearbhaill, R. E.; Park, J. H.; Halton, E. F.; Diamonte, C. R.; Mead, E.; Lakhman, Y.; Kane, P.; Riviere, I. C.; Brentjens, R. J. |
| Abstract Title: | A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MUC16ecto+ recurrent high-grade serous ovarian cancer (HGSOC) |
| Meeting Title: | 51st Annual Meeting of the Society of Gynecologic Oncology (SGO) |
| Journal Title: | Gynecologic Oncology |
| Volume: | 159 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Mar 28-31 |
| Meeting Location: | Toronto, Canada |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-10-01 |
| Start Page: | 42 |
| Language: | English |
| ACCESSION: | WOS:000579556200085 |
| DOI: | 10.1016/j.ygyno.2020.06.089 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 54 -- This meeting was cancelled due to COVID-19 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work